Unified Patent Court (UPC) analytics are now available. Check here

Law FirmOpposition Filing Analysis

The comprehensive analysis of Lederer & Keller Patentanwalte Partnerschaft Mbb opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Lederer & Keller Patentanwalte Partnerschaft Mbb

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3574914Corticosteroid CompositionsMERITAGE PHARMASep 1, 2022DR FALK PHARMA
EP3464373Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal CancerBRISTOL MYERS SQUIBBJul 26, 2022LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB
EP3437645Film-Coated Tablet Having High Chemical Stability Of Active IngredientINTERCEPT PHARMACEUTICALSJun 21, 2022SANDOZ
EP2585075Methods Of Treatment For Esophageal InflammationVIROPHARMA BIOLOGICSMay 4, 2022DR FALK PHARMA
EP2863895Tablet Formulation Comprising A Peptide And A Delivery AgentNOVO NORDISKJan 11, 2022TEVA PHARMACEUTICAL INDUSTRIES
EP3094681Propylene-Based Impact CopolymersEXXONMOBIL CHEMICAL PATENTSOct 19, 2021LUMMUS NOVOLEN TECHNOLOGY
EP2545939Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of MeasuringBIOMARIN PHARMACEUTICALSep 14, 2021TEVA PHARMACEUTICAL INDUSTRIES
EP3337467Combination Therapy Using Liposomal Irinotecan And A Parp Inhibitor For Cancer TreatmentIPSEN BIOPHARMSep 9, 2021SANDOZ
EP2478907Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGYJul 6, 2021TEVA PHARMACEUTICAL INDUSTRIES
EP3060582Assays For Determining Plasma Kallikrein System BiomarkersTAKEDA PHARMACEUTICALJun 23, 2021LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB